Anti-IL-12 antibodies, epitopes, compositions, methods and uses

Details for Australian Patent Application No. 2012203565 (hide)

Owner Centocor, Inc.

Inventors Heavner, George; Giles-Komar, Jill; Knight, David; Luo, Jinquan; Peritt, David; Scallon, Bernard; Shealy, David

Agent Shelston IP

Pub. Number AU-A-2012203565

Parent 2005319278

Filing date 19 June 2012

Wipo publication date 12 July 2012

International Classifications

C12N 5/10 Undifferentiated human, animal or plant cells, e.g. cell lines - Cells modified by introduction of foreign genetic material, e.g. virus-transformed cells

A61K 39/395 Medicinal preparations containing antigens or antibodies - Antibodies

C07K 16/24 Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C12N 15/12 Mutation or genetic engineering - Genes encoding animal proteins

C12N 15/13 Mutation or genetic engineering - Immunoglobulins

C12N 15/62 Mutation or genetic engineering - DNA sequences coding for fusion proteins

C12N 15/63 Mutation or genetic engineering - Introduction of foreign genetic material using vectors

Event Publications

5 July 2012 Complete Application Filed

12 July 2012 Application Open to Public Inspection

  Published as AU-A-2012203565

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2012203566-Topical formulations for the prevention of sexually transmitted disease and methods of producing the same (61) 2008351414

2012203564-Compositions and methods for treating and diagnosing cancer